IRF1 and NF-kB Restore MHC Class I-Restricted Tumor Antigen Processing and Presentation to Cytotoxic T Cells in Aggressive Neuroblastoma
Open Access
- 5 October 2012
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 7 (10), e46928
- https://doi.org/10.1371/journal.pone.0046928
Abstract
Neuroblastoma (NB), the most common solid extracranial cancer of childhood, displays a remarkable low expression of Major Histocompatibility Complex class I (MHC-I) and Antigen Processing Machinery (APM) molecules, including Endoplasmic Reticulum (ER) Aminopeptidases, and poorly presents tumor antigens to Cytotoxic T Lymphocytes (CTL). We have previously shown that this is due to low expression of the transcription factor NF-kB p65. Herein, we show that not only NF-kB p65, but also the Interferon Regulatory Factor 1 (IRF1) and certain APM components are low in a subset of NB cell lines with aggressive features. Whereas single transfection with either IRF1, or NF-kB p65 is ineffective, co-transfection results in strong synergy and substantial reversion of the MHC-I/APM-low phenotype in all NB cell lines tested. Accordingly, linked immunohistochemistry expression patterns between nuclear IRF1 and p65 on the one hand, and MHC-I on the other hand, were observed in vivo. Absence and presence of the three molecules neatly segregated between high-grade and low-grade NB, respectively. Finally, APM reconstitution by double IRF1/p65 transfection rendered a NB cell line susceptible to killing by anti MAGE-A3 CTLs, lytic efficiency comparable to those seen upon IFN-γ treatment. This is the first demonstration that a complex immune escape phenotype can be rescued by reconstitution of a limited number of master regulatory genes. These findings provide molecular insight into defective MHC-I expression in NB cells and provide the rational for T cell-based immunotherapy in NB variants refractory to conventional therapy.Keywords
This publication has 53 references indexed in Scilit:
- Late SV40 Factor (LSF) Enhances Angiogenesis by Transcriptionally Up-regulating Matrix Metalloproteinase-9 (MMP-9)Published by Elsevier BV ,2012
- Towards a systems understanding of MHC class I and MHC class II antigen presentationNature Reviews Immunology, 2011
- Recent Advances in NeuroblastomaThe New England Journal of Medicine, 2010
- Modulation of SOCS protein expression influences the interferon responsiveness of human melanoma cellsBMC Cancer, 2010
- CD40 Induces Antigen Transporter and Immunoproteasome Gene Expression in Carcinomas via the Coordinated Action of NF-κB and of NF-κB-Mediated De Novo Synthesis of IRF-1Molecular and Cellular Biology, 2008
- MAGE-A1 expression is associated with good prognosis in neuroblastoma tumorsZeitschrift für Krebsforschung und Klinische Onkologie, 2008
- Cancer testis antigens in human melanoma stem cells: Expression, distribution, and methylation statusJournal of Cellular Physiology, 2008
- Multiple defects of the antigen-processing machinery components in human neuroblastoma: immunotherapeutic implicationsOncogene, 2005
- Role of myeloablative therapy in improved outcome for high risk neuroblastoma: Review of recent children's cancer group resultsEuropean Journal of Cancer, 1995
- Association of Multiple Copies of the N-mycOncogene with Rapid Progression of NeuroblastomasThe New England Journal of Medicine, 1985